LEO ALEXANDER, M.D.; LEO J. CASS, M.D.
Many investigators have used adrenocorticotrophic hormone (ACTH) in the treatment of multiple sclerosis. Information being accumulated clearly delineates the effectiveness of such treatment in this kind of progressive disease. In a series of 43 patients treated with ACTH, 18 of whom were compared with controls matched by age, sex, duration of illness, and disability score at the time of treatment and over the preceding 3 to 12 months, the degree of improvement, evaluated in terms of a pre-established scoring system, was found to be statistically significant (1, 2). In a study by Miller, Newell, and Ridley (3) a similar dosage
ALEXANDER L, CASS LJ. The Present Status of ACTH Therapy in Multiple Sclerosis. Ann Intern Med. ;58:454–471. doi: 10.7326/0003-4819-58-3-454
Download citation file:
Published: Ann Intern Med. 1963;58(3):454-471.
Multiple Sclerosis, Neurology.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use